Institute for Stem Cell Biology and Regenerative Medicine, Department of Obstetrics and Gynecology, Hagey Laboratory for Pediatric Regenerative Medicine, Department of Surgery, and Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA.
Stem Cells Transl Med. 2014 Jan;3(1):91-7. doi: 10.5966/sctm.2013-0124. Epub 2013 Dec 5.
Smooth muscle cells (SMCs) and endothelial cells (ECs) are typically derived separately, with low efficiencies, from human pluripotent stem cells (hPSCs). The concurrent generation of these cell types might lead to potential applications in regenerative medicine to model, elucidate, and eventually treat vascular diseases. Here we report a robust two-step protocol that can be used to simultaneously generate large numbers of functional SMCs and ECs from a common proliferative vascular progenitor population via a two-dimensional culture system. We show here that coculturing hPSCs with OP9 cells in media supplemented with vascular endothelial growth factor, basic fibroblast growth factor, and bone morphogenetic protein 4 yields a higher percentage of CD31(+)CD34(+) cells on day 8 of differentiation. Upon exposure to endothelial differentiation media and SM differentiation media, these vascular progenitors were able to differentiate and mature into functional endothelial cells and smooth muscle cells, respectively. Furthermore, we were able to expand the intermediate population more than a billion fold to generate sufficient numbers of ECs and SMCs in parallel for potential therapeutic transplantations.
平滑肌细胞(SMCs)和内皮细胞(ECs)通常是从人类多能干细胞(hPSCs)中分别、低效率地分化而来。这些细胞类型的同时产生可能会导致在再生医学中的潜在应用,以模拟、阐明和最终治疗血管疾病。在这里,我们报告了一种稳健的两步法方案,可通过二维培养系统从共同的增殖性血管祖细胞群中同时大量生成功能性 SMC 和 EC。我们在这里表明,在含有血管内皮生长因子、碱性成纤维细胞生长因子和骨形态发生蛋白 4 的培养基中与 OP9 细胞共培养可使 hPSCs 在分化的第 8 天产生更高比例的 CD31(+)CD34(+)细胞。暴露于内皮细胞分化培养基和 SM 分化培养基后,这些血管祖细胞能够分化并成熟为功能性内皮细胞和平滑肌细胞。此外,我们能够将中间群体扩增超过十亿倍,以便为潜在的治疗性移植平行生成足够数量的 EC 和 SMC。